Closing Thoughts on ASCVD Management

In the final episode, 'Closing Thoughts on ASCVD Management,' the panelists explore what meaningful, systemic change would look like in cardiovascular prevention, opening with the observation that early and consistent attention to lifestyle, blood pressure, and cholesterol management could reduce cardiovascular disease mortality by as much as 75%. The discussion identifies several interconnected levers for closing the treatment gap, including the integration of automated risk assessment tools within electronic medical records in primary care settings, structured wellness touchpoints that remove the burden of prevention from overstretched practitioners, and algorithmic treatment pathways that allow clinicians to anticipate the combination therapy intensity needed to reach a patient's LDL goal from the outset rather than waiting through sequential adjustments. One panelist notes that with currently available tools and a streamlined approach, it is theoretically possible to get virtually all patients to their LDL goal within approximately three months using eight clearly defined steps. The panel also reflects on the misalignment between healthcare reimbursement structures and preventive care, with one panelist noting that procedural and diagnostic services continue to be rewarded far more generously than prevention-focused practice, representing a fundamental systemic barrier to implementation.

The episode closes with final thoughts from each panelist, converging on a shared message of urgency and optimism. The panel emphasizes that the tools to achieve guideline-recommended LDL targets already exist, and that the primary remaining challenges are consistent measurement, diligent follow-up, and sustained patient engagement. Panelists stress the importance of establishing a baseline lipid panel before initiating therapy and repeating testing regularly to confirm both efficacy and adherence, proactively inviting patients to share concerns that might otherwise lead to silent discontinuation. The series concludes with a call to action grounded in the principles of personalized medicine, reminding clinicians that assessing individual risk, setting clear LDL targets, combining lifestyle and pharmacotherapy appropriately, and maintaining an ongoing partnership with each patient are the cornerstones of meaningful ASCVD prevention and treatment.

Thank you for watching this Peer Exchange series on ASCVD. Please subscribe to our newsletter for information on upcoming video series.